Tibet AIM Pharm. Inc. (002826.SZ)

Tibet AIM Pharm. Inc. (002826.SZ) — VMCI valuation read

The headline on Tibet AIM Pharm. Inc. (002826.SZ) is a 55/100 VMCI score, set against a Healthcare sector median of 50. That 5-point above-median read reflects the five-pillar weighting and, for a mid-cap name, suggests a relative-value tailwind is in the data.

002826.SZ insider activity report: 0 buys, 0 sells filed via Form 4 over the past 30 days. The next datable items are the 10-Q schedule and any 8-K-triggering events; both feed the VMCI Integrity pillar more than the price tape.

**Investor frame.** 002826.SZ trades at 19.0x earnings, 6% above the Healthcare median of 18.0x sets the value side. ROIC of 15.0% sits 5.0pp above the Healthcare median (10.0%) sets the quality side. Net debt to EBITDA of 2.0x is the rate-sensitivity line to watch sets the risk side, the three lines a value buyer reads first on 002826.SZ.

002826.SZ fell 3.2% over the trailing 7 days, with a +4.9% read on a 30-day basis.